YizhenPang   

AssociateProfessor

Work Experience

2025.07-present 人员未提供单位信息

Education background

MD,Oncology, Xiamen University, 2025

MSc,Nuclear Medicine, Xiamen University     

BSc,Medical radiology, Taishan Medical University         

Research interest

Molecularimaging of cancer   

Publications

1.Pang Yizhen†, Zhao Liang†, Luo Zuoming, Hao Bing, Wu Hua, LinQin, Sun Long, Chen Haojun*. Comparison of 68Ga-FAPI and 18F-FDG Uptake inGastric, Duodenal, and Colorectal Cancers. Radiology. 2021Feb;298(2):393-402.

2.Chen Haojun†*, Zhao Liang†, Pang Yizhen†, Shi Jiyun†, GaoHaonan, Sun Yining, Chen Jianhao, Fu Hao, Cai Jiayu, Yu Lingyu, Zeng Ru, SunLong, Wu Hua, Wang Zhanxiang*, Wang Fan*. 68Ga-MY6349 PET/CT imaging to assessTrop2 expression in multiple types of cancer. J Clin Invest. 2024Nov 7;135(1):e185408.

3.Pang Yizhen†, Zhao Liang†, Fang Jianyang†, Chen Jianhao, MengLingxin, Sun Long, Wu Hua, Guo Zhide*, Lin Qin, Chen Haojun*. Development ofFAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI RadioligandTherapy. J Nucl Med. 2023 Sep;64(9):1449-1455.

4.Pang Yizhen†, Zhao Liang†, Meng Tinghua†, Xu Weizhi, Lin Qin, WuHua, Zhang Jingjing, Chen Xiaoyuan*, Sun Long*, Chen Haojun*. PET Imaging ofFibroblast Activation Protein in Various Types of Cancer Using 68Ga-FAP-2286:Comparison with 18F-FDG and 68Ga-FAPI-46 in a Single-Center, Prospective Study.J Nucl Med. 2023 Mar;64(3):386-394.

5.Zhao Liang†, Pang Yizhen†, Zhou Yangfan†, Chen Jianhao†, Fu Hao,Guo Wei, Xu Weizhi, Xue Xin, Su Guoqiang, Sun Long, Wu Hua, Zhang Jingjing,Wang Zhanxiang, Lin Qin*, Chen Xiaoyuan*, Chen Haojun*. Antitumor efficacy andpotential mechanism of FAP-targeted radioligand therapy combined with immunecheckpoint blockade. Signal Transduct Target Ther. 2024 Jun3;9(1):142.

6.Pang Yizhen†, Zhao Long†, Shang Qihang†, Meng Tinghua, ZhaoLiang, Feng Liuxing, Wang Shuangjia, Guo Ping, Wu Xiurong, Lin Qin, Wu Hua,Huang Weipeng*, Sun Long*, Chen Haojun*.Positron emission tomography andcomputed tomography with [68Ga]Ga-fibroblast activation protein inhibitorsimproves tumor detection and staging in patients with pancreatic cancer. EurJ Nucl Med Mol Imaging. 2022;49(4):1322-1337.

Research Grant:

1.Taishan Scholar Young Expert;

2.SecondPrize for Scientific and Technological Progress in Xiamen City;

3.ThirdPrize for Scientific and Technological Progress in Fujian Province;

4.ChinaAssociation for Science and Technology's Special Program for Supporting YoungTalents as Doctoral Students;

5. 2024SNMMI Alavi-Mandell;

E-mail:pyz15980890201@163.com